Back to results
US 2003/0166138 A1Published application
Cyclic peptides and analogs useful to treat allergies
OwnerTodd Kinsella, Cara Ohashi +1inventors
InventorsTodd Kinsella, Cara Ohashi, Dave Anderson
Life of this patent
Estimating the term…
Abstract
The present provides cyclic compounds capable of modulating IgE production, as well as IL-4 induced processes associated therewith, and methods of using the cyclic compounds in a variety of in vitro and in vitro contexts.
Claims52
A cyclic compound composed of from 4 to 10 residues comprising a contiguous sequence of residues selected from structures (Ia)-(Ie):
- X26˜X25˜X21˜X25;
- (Ia) X22˜X24˜X27˜X29;
- (Ib) X21˜X22˜X24˜X29;
- (Ic) X22˜X21˜X21˜X29;
- (Id) X28˜Glu˜X21˜X29;and (Ie)
- pharmaceutically acceptable salt thereof, wherein:
- each X21 is independently a small residue;
- each X22 is independently a basic residue;
- each X24 is independently a hydrophobic residue;
- each X25 is independently an aromatic residue;
- each X26 is independently a polar residue;
- each X27 is independently a small or a cysteine-like residue;
- each X28 is independently a small or an acidic residue;
- and
- each X29 is independently any residue;
- and
- each “˜” independently represents an amide, a substituted amide, an isostere of an amide or an amide or peptido mimetic linkage.
14 more elements
Dependencies are inferred from the claim text.